Brain, Lung, and Ovarian Cancers Selected to Initiate The Cancer Genome Atlas
The cancers to be studied first in the pilot phase of The Cancer Genome Atlas (TCGA) project will be brain, lung, and ovarian, officials from NCI and the National Human Genome Research Institute (NHGRI) announced on September 13.
The Institutes launched the pilot phase of TCGA in December 2005 to assess the feasibility of systematically identifying the significant genomic changes involved in cancer using contemporary genomic analysis technologies, including resequencing of selected genes. Read more
A Vision of Progress
Now that it is official, let me emphasize once again what a special honor it is to lead the world's preeminent cancer research organization, especially at a time when our opportunities for progress are without precedent.
There is broad agreement among NCI leaders about how best to seize these opportunities. First, we must continue to address NCI's strategic priorities, through appropriately aligned new initiatives. Second, we are committed to striving to maintain the number of competing awards near the level achieved during the period when the NIH budget doubled. In addition, we are firmly committed to funding new investigators and devising incentives that will attract the best minds to a field so vital to the health of our citizens - and to our country's future development in a changing world market.
Sound fiscal planning, especially in today's difficult budgetary environment, will be required to achieve these goals. Read more